Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,4 CAD | -2,44% | -16,67% | -6,98% |
27/03 | Satellos Bioscience Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 | CI |
27/03 | Satellos Bioscience annonce ses résultats pour l'exercice 2023 | MT |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Frank Gleeson
FOU | Founder | 68 | 01/01/18 |
Michael Rudnicki
FOU | Founder | - | 01/01/18 |
Director of Finance/CFO | - | 01/09/23 | |
Courtney Wells
COO | Chief Operating Officer | - | - |
J. Hall
ADM | Chief Administrative Officer | - | 01/01/20 |
Philip Lambert
CTO | Chief Tech/Sci/R&D Officer | 56 | 27/09/22 |
Ryan Mitchell
PRN | Corporate Officer/Principal | - | - |
Michael B. Cross
PRN | Corporate Officer/Principal | 59 | - |
Warren Whitehead
PRN | Corporate Officer/Principal | 71 | 13/08/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | - |
Geoff MacKay
CHM | Chairman | 57 | 01/09/18 |
William McVicar
BRD | Director/Board Member | 66 | - |
Brian Bloom
BRD | Director/Board Member | 48 | 01/04/18 |
Michael Rudnicki
FOU | Founder | - | 01/01/18 |
Frank Gleeson
FOU | Founder | 68 | 01/01/18 |
Adam Mostafa
BRD | Director/Board Member | 44 | 05/12/21 |
William Jarosz
BRD | Director/Board Member | - | - |
Rima Al-awar
BRD | Director/Board Member | - | 05/12/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 112 791 658 | 98 752 661 ( 87,55 %) | 0 | 87,55 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-6,98% | 32,97 M | |
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+38,61% | 12,63 Md | |
+313,59% | 8,49 Md |
- Bourse
- Actions
- Action MSCL
- Société Satellos Bioscience Inc.